Listar por autor "Juan-Bagudá, Javier de"

Mostrando ítems 1-2 de 2

    • Hyperkalemia in Heart Failure Patients in Spain and Its Impact on Guidelines and Recommendations: ESC-EORP-HFA Heart Failure Long-Term Registry 

      Crespo-Leiro, María Generosa; Barge-Caballero, Eduardo; Segovia-Cubero, Javier; González-Costello, José; López-Fernández, Silvia; García-Pinilla, José Manuel; Almenar-Bonet, Luis; Juan-Bagudá, Javier de; Roig-Minguell, Eulalia; Bayés-Genís, Antoni; Sanz-Julve, Marisa; Lambert Rodríguez, José Luis; Lara-Padrón, Antonio; Pérez-Ruiz, José María; Fernández-Vivancos Marquina, Carla; De la Fuente-Galán, Luis; Varela-Román, Alfonso; Torres-Calvo, Francisco; Andrés-Novales, Javier; Escudero-González, Aida; Pascual-Figal, Domingo A.; Ridocci-Soriano, Francisco; Sahuquillo-Martínez, Ana; Bierge-Valero, David; Epelde-Gonzalo, Francisco; Gallego-Page, Juan Carlos; Dalmau González-Gallarza, Regina; Bover-Freire, Ramón; Quiles-Granado, Juan; Pietro Maggioni, Aldo; Lund, Lars H.; Muñiz, Javier; Delgado Jiménez, Juan Francisco (Elsevier, 2020-04)
      [Abstract] Introduction and objectives: Hyperkalemia is a growing concern in the treatment of patients with heart failure and reduced ejection fraction because it limits the use of effective drugs. We report estimates of ...

    • Prevalence, Incidence, and Outcomes of Hyperkalaemia in Patients with Chronic Heart Failure and Reduced Ejection Fraction from a Spanish Multicentre Study: SPANIK-HF Design and Baseline Characteristics 

      Delgado-Jiménez, Juan F.; Segovia-Cubero, Javier; Almenar-Bonet, Luis; Juan-Bagudá, Javier de; Lara-Padrón, Antonio; García-Pinilla, José Manuel; Bonilla-Palomas, Juan Luis; López-Fernández, Silvia; Mirabet-Pérez, Sonia; Gómez-Otero, Inés; Castro-Fernández, Antonio; Díaz-Molina, Beatriz; Goirigolzarri-Artaza, Josebe; Rincón-Pérez, Luis Miguel; Pascual-Figal, Domigo A.; Anguita-Sánchez, Manuel; Muñiz, Javier; Crespo-Leiro, María Generosa (MDPI, 2022-02-22)
      [Abstract] Hyperkalaemia is a growing concern in the treatment of patients with heart failure and reduced ejection fraction (HFrEF) as it limits the use of some prognostic-modifying drugs and has a negative impact on ...